Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Key: Taisho Toyama Pharmaceutical Ltd. (0) Acquired (10)
azithromycin (zithromax) (1 trial)
diclofenac (voltaren) (1 trial)
esflurbiprofen (1 trial)
favipiravir (2 trials)
human autologous synovial stem cells (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
ozoralizumab (1 trial)
t-614 (1 trial)
ts-142 (16 trials)
zinc sulfate (1 trial)
Key: Taisho Toyama Pharmaceutical Ltd. (0) Acquired (6)
Edonerpic (4 trials)
enerisant (2 trials)
ts022 (1 trial)
ts-121 (2 trials)
ts-161 (2 trials)
ts-172 (2 trials)
Key: Taisho Toyama Pharmaceutical Ltd. (0) Acquired (7)
itraconazole (sporanox) (1 trial)
moxifloxacin (avelox) (1 trial)
pf-04802540 (3 trials)
tasp0410699 (1 trial)
ts-134 (3 trials)
ts-143 (3 trials)
zopiclone (Zimovane) (2 trials)
Trials (44 total)
Trial APIs (23 total)